Drawing for M

USPTO serial 86913629

M

Reviewed by CopyMark Law Group

Reg. 6115662Status 700Renewal
Filing date
Status date
Registration date
Aug 4, 2020
Examiner
SHINER, MARK W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with M?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle P. Ciotola

Michelle P. Ciotola CANTOR COLBURN LLP20 Church StreetFloor 22Hartford, CT 06103-1253

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for treatment of infectious diseases, chronic diseases and cancerACTIVE—
040Manufacture of pharmaceuticals, pharmaceutical ingredients, vaccines and antibodies for othersACTIVE—
042Research and development in the field of vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; medical and scientific research regarding clinical trial studies on new vaccine candidates; development of pharmaceuticals, pharmaceutical ingredients, vaccines, and antibodiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 11, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 11, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 11, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 4, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 4, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 4, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 4, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 4, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 4, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 4, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 19, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 19, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 13, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 27, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 27, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 1, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 1, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 1, 2019CNSISUSPENSION INQUIRY WRITTEN—
Mar 18, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 18, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Mar 18, 2019CNSLSUSPENSION LETTER WRITTEN—
Mar 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Sep 21, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Sep 21, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Sep 21, 2018CNSISUSPENSION INQUIRY WRITTEN—
Mar 21, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 21, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Mar 21, 2018CNSLSUSPENSION LETTER WRITTEN—
Mar 21, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 20, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 26, 2017GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Oct 26, 2017GNSIINQUIRY TO SUSPENSION E-MAILED—
Oct 26, 2017CNSISUSPENSION INQUIRY WRITTEN—
Oct 24, 2017RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 24, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 24, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Apr 24, 2017CNSLSUSPENSION LETTER WRITTEN—
Apr 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 12, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 5, 2017ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 11, 2016GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Nov 11, 2016GNSIINQUIRY TO SUSPENSION E-MAILED—
Nov 11, 2016CNSISUSPENSION INQUIRY WRITTEN—
May 11, 2016GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 11, 2016GNSLLETTER OF SUSPENSION E-MAILED—
May 11, 2016CNSLSUSPENSION LETTER WRITTEN—
May 11, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 6, 2016ALIEASSIGNED TO LIE—
Apr 22, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2016DOCKASSIGNED TO EXAMINER—
Feb 26, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Feb 25, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance